Clinical Trial Update: Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of the Bimatoprost Implant System used in combination with the SpyGlass intraocular lens, compared to Timolol o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Bimatoprost Implant System (bimatoprost)
• Timolol ophthalmic solution (timolol)

Snippet

Sponsor: SpyGlass Pharma, Inc. | Conditions: Cataract, Glaucoma | Phase 3 | Status: RECRUITING